Abbreviation {#nomen0010}
============

HFD

:   high-fat diet

NAFLD

:   nonalcoholic fatty liver disease

NASH

:   nonalcoholic steatohepatitis

MCP-1

:   monocyte chemotactic protein-1

TF

:   tissue factor

PAI-1

:   plasminogen activator inhibitor-1

ER

:   endoplasmic reticulum

Con A

:   concanavalin A

F

:   coagulation factor

NAFL

:   nonalcoholic fatty liver

NK

:   natural killer

KC

:   Kupffer cell

LSEC

:   liver sinusoidal endothelial cell

HSC

:   hepatic stellate cell

GRO1

:   melanoma growth stimulating activity, alpha

IP-10

:   interferon gamma-induced protein 10

NKT

:   natural killer T

ND

:   normal diet

ALT

:   alanine aminotransferase

T-Cho

:   total cholesterol

TG

:   triglyceride

Glu

:   glucose

H&E

:   haematoxylin & eosin

8-OHdG

:   8-hydroxy-2′-deoxyguanosine

qRT-PCR

:   quantitative real-time reverse-transcription polymerase chain reaction

SD

:   standard deviations

HK-4

:   hexokinase-4

GPI-1

:   glucose-6-phosphatase isomerase

PDK4

:   pyruvate dehydrogenase kinases 4

Fbg-α

:   fibrinogen-α

BiP

:   binding immunoglobulin protein

XBP-1

:   X-box-binding protein

ATF4

:   activating transcription factor 4

ATF6

:   activating transcription factor 6

CHOP

:   C/EBP homologous protein

ERAD

:   ER associated degradation

HIF-1α

:   hypoxia-inducible factor-1α

HO-1

:   heme oxygenase-1

MnSOD

:   Mn-superoxide dismutase

IRE1

:   inositol requiring 1

ICAM-1

:   intercellular adhesion molecule-1

VCAM-1

:   vascular cell adhesion molecule-1

NFκB

:   nuclear factor-κB

ROS

:   reactive oxygen species

1. Introduction {#sec1}
===============

In obesity, adipose tissues release TNF-α, IL-6, MCP-1, and PAI-1, causing proinflammatory and procoagulation states \[[@bib1]\]. In addition, it has been reported that plasma levels of coagulation factors (F) VII, VIII, XII, fibrinogen, and PAI-1 are increased in obese subjects \[[@bib2],[@bib3]\].

Epidemiological studies have shown a positive relationship between HFD intake and obesity \[[@bib4]\]. And it has recently been reported in mice model that relatively short-term (for 14 days) HFD intake also induces increase of plasma levels of inflammatory cytokines (IL-1β, IL-6, and IL-12) and coagulation factors (fibrinogen, FII, FVII, etc.) \[[@bib5]\]. This suggests that HFD intake itself causes proinflammatory and procoagulation states and leads to the complication seen in the obesity, such as thromboembolic cardiovascular events.

Since obesity is frequently accompanied by NAFLD, it is not surprising that procoagulation state is present in patients with NAFLD, and that it affects the course of the disease.

NAFLD is classified into nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH); the latter sometimes leads to liver cirrhosis and liver cancer \[[@bib6]\]. When the disease concept of NASH was established, "two hit theory" was proposed to explain the pathogenesis mechanism of the disease. Namely, "the first hit," hepatic steatosis, increases susceptibility of hepatocytes to the damage mediated by "the second hits," such as inflammatory cytokines/adipokines (TNF-α, MCP-1, PAI-1, etc.), adipokine imbalance, oxidative stress/mitochondrial dysfunction, ER stress, gut-derived endotoxin, and secondary bile acid. And these "two hits" are thought to contribute to the development of steatohepatitis and subsequent liver fibrosis cooperatively \[[@bib7]\]. Recently, "multiple parallel hit theory" in which multiple parallel factors including so-called "first hit" and "second hits" act simultaneously and synergistically to induce NAFLD/NASH, is more widely accepted \[[@bib8]\]. But the mechanism of the pathogenesis of NASH has not been fully clarified.

Con A is a lectin known to induce acute liver injury in rodents through the modulation of migrating inflammatory cells and hepatic non-parenchymal cells, including T cells, monocytes, Kupffer cells (KCs), liver sinusoidal endothelial cells (LSECs), and hepatic stellate cells (HSCs) \[[@bib9], [@bib10], [@bib11], [@bib12], [@bib13], [@bib14]\]. When administered in mice, Con A binds to receptors of KCs and LSECs, and these Con A-bound cells stimulate T cells to secrete immunogenic cytokines such as IFN-γ and TNF-α, which subsequently induce apoptotic cell death in hepatocytes \[[@bib12]\]. Moreover, it has been demonstrated that binding of Con A stimulates HSCs to produce IFN-β, TNF-α, melanoma growth stimulating activity, alpha (GRO1), and interferon gamma-induced protein 10 (IP-10), resulting in the recruitment and activation of inflammatory cells, including T cells, natural killer T (NKT) cells, and neutrophils, all of which contribute to the development of acute liver injury \[[@bib13],[@bib14]\]. In addition, it has been reported that IFN-γ and TNF-α produced from Con A-stimulated cells increase hepatic expression of TF and PAI-1, resulting in the induction of procoagulation state which causes thrombus formation in sinusoids and extensive liver necrosis \[[@bib15]\].

It has been demonstrated that recruitment and activation of liver-resident and non-resident cells, including T cells, neutrophils, NK cells, KCs, LSECs, and HSCs, are involved in the developing process from NAFL to NASH \[[@bib16],[@bib17]\]. Since most of these cell lineages were involved in the pathogenesis process of Con A-induced liver injury, we thought that it appropriately reproduces the events induced by so-called "second hits" in the NASH pathogenesis.

In the current study, we examined if short-term HFD intake caused proinflammatory and procoagulation states in the liver, and if it caused exacerbation of liver damage in the mouse model of Con A-induced liver injury.

2. Materials and methods {#sec2}
========================

2.1. Animals and diet compositions {#sec2.1}
----------------------------------

C57BL/6 male mice of 5--6 weeks of age were obtained from Japan SLC Inc. (Shizuoka, Japan), and housed in a controlled environment (12 h light/dark cycles at 25 °C). They were fed with normal diet (ND: CE2, CLEA Japan Inc., Tokyo, Japan) as baseline diet, and subsequently fed with HFD (High Fat Diet 32, CLEA Japan Inc.) for certain period depending on the experimental designs. The compositions of the diets are summarized in [Table 1](#tbl1){ref-type="table"}. All the experiments were done using mice of 8 weeks of age, and five groups of mice were prepared for the experiments: ND, mice fed with ND only; HFD1, mice fed with HFD for 1 day; HFD2, mice fed with HFD for 2 days: HFD4, mice fed with HFD for 4 days; HFD14, mice fed with HFD for 14 days before becoming 8 weeks of age. Bleeding from the orbital veins and sacrifice of mice were done under anesthesia with isoflurane (Pfizer Japan Inc., Tokyo, Japan). All conditions and handing of animals in this study were conducted under the protocols approved by Nagoya University (approval number 031--036).Table 1Diet compositions of normal diet (ND) and high-fat diet (HFD).Table 1Nutritional compositionCE2High Fat Diet 32(per 100g diet)(ND: normal diet)(HFD: high fat diet)Moisture (%)8.846.2Crude protein (%)25.4825.5Crude fat (%)4.6132Crude fiber (%)5.142.9Crude ash (%)7.014Nitrogen free extract (NFE) (%)48.9229.4Energy (kcal)339.1507.6

2.2. Influence of diet consumption {#sec2.2}
----------------------------------

Three groups of mice: ND, HFD4, and HFD14 (n = 5, respectively) were bled and sacrificed at 8 weeks of age ([Fig. 1](#fig1){ref-type="fig"}A). The sera and resected livers of the mice were subjected to the analyses: sera for biochemical and coagulation-related tests, and resected livers for analyses of histology and mRNA expression levels of the genes related to cytokine/chemokine, cell surface marker, coagulation, metabolism, and cellular stresses. To examine the plasma levels of coagulation-related factors, four groups of mice: ND, HFD1, HFD2, and HFD4 (n = 4, respectively) were bled at 8 weeks of age, and collected plasma was subjected to the analysis ([Fig. 1](#fig1){ref-type="fig"}A). Collection of blood and liver sections was performed under fed condition to avoid changes in biochemical data and hepatic gene expression caused by fasting.Fig. 1Serum biochemistry and liver histology.(A) Experimental scheme. ND: the mice fed with ND, HFD1, HFD2, HFD4 and HFD14: the mice fed with HFD for 1 day, 2 days, 4 days and 14 days, respectively. (B) The results of serum ALT (U/l), total cholesterol (T-Cho, mg/dl), triglyceride (TG, mg/dl), and glucose (Glu, mg/dl). The data are shown as means ± SD. \*p \< 0.05. (C) H&E and fibrin/fibrinogen immunostaining of representative liver sections from the individual groups of mice. In each group, the left column shows H&E-staining and the right column shows fibrin/fibrinogen immunostaining. 4× objective\'s scale bar: 200 μm 10× objective\'s scale bar: 50 μm 20× objective\'s scale bar: 20 μm (D) Oil Red O staining of representative liver sections from the individual groups of mice. 4× objective\'s scale bar: 200 μm 10× objective\'s scale bar: 50 μm 20× objective\'s scale bar: 20 μm. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)Fig. 1Fig. 2Hepatic mRNA expression.Intrahepatic mRNA expression levels were measured by qRT-PCR. Expression levels of the respective mRNAs are normalized to that of GAPDH and normalized data are presented as fold change compared with ND-fed mice. The data are shown as means ± SD. \*P \< 0.05 vs. ND-fed mice.Fig. 2

2.3. Concanavalin A-induced liver injury in ND- and HFD-fed mice {#sec2.3}
----------------------------------------------------------------

Three groups of mice: ND, HFD4, and HFD14 (ND, n = 5; HFD4, n = 6; HFD14, n = 6) under fed condition, were intravenously administered with 10 mg/kg body weight of Con A (Fujifilm Wako Pure Chemical Corp. (Fujifilm Wako), Osaka, Japan) dissolved in phosphate-buffered saline (PBS, Fujifilm Wako). The final administration dose of Con A solution was of 200 μl/25 g body weight. Five mice from each group (ND, HFD4, and HFD14) were administered with PBS only (200 μl), and served as controls. Twenty-four hours after Con A or PBS administration, all the mice were bled and sacrificed. The sera and resected livers of all the mice were subjected to the analyses ([Fig. 3](#fig3){ref-type="fig"}A).Fig. 3Extent of Con A-induced liver injury.(A) Experimental scheme. (B) Serum ALT levels 24 h after Con A administration. The data are shown as means ± SD (U/l). \*p \< 0.05. (C) H&E staining of representative liver sections. From left to right, ND mice without Con A administration, ND, HFD4, and HFD14 mice, 24 h after Con A administration, respectively. 4× objective\'s scale bar: 200 μm 10× objective\'s scale bar: 50 μm (D) Fibrin/fibrinogen immunostaining of serial liver sections from the same mice as (C). 4× objective\'s scale bar: 200 μm 10× objective\'s scale bar: 50 μm 20× objective\'s scale bar: 20 μm.Fig. 3

For the time-course experiment, ND and HFD4 mice administered with Con A (n = 21 for each group) were bled and sacrificed at 1, 3, 24 h after Con A administration (n = 6 for controls without Con A administration, and n = 5 for the individual time points, in both ND and HFD4, [Fig. 4](#fig4){ref-type="fig"}A). The sera and resected livers of all the mice were subjected to the analyses.Fig. 4Sequential changes of serum ALT levels, histology and hepatic mRNA expressions in ND and HFD-fed mice in the early phase of Con A-induced liver injury.(A) Experimental scheme. (B) The results of serum ALT (U/l). \*p \< 0.05.(C) H&E staining of representative liver sections. Left panel shows the histology of ND mice and right panel shows that of HFD4 mice. In each panel, from left to right, histology of the mice with 1 h, 3 h, or 24 h after Con A administration, respectively. 4× objective\'s scale bar: 200 μm 10× objective\'s scale bar: 50 μm (D) Intrahepatic mRNA expression levels measured by qRT-PCR. \*p \< 0.05.Fig. 4

2.4. Treatment with heparin against concanavalin A-induced liver injury {#sec2.4}
-----------------------------------------------------------------------

ND and HFD4 mice (ND, n = 6; HFD4, n = 7) were subcutaneously injected with 5,000 U/kg body weight of heparin (Novo-Heparin, Mochida Pharmaceutical, Tokyo, Japan) 30 min before Con A (10 mg/kg body weight) administration. ND and HFD4 mice (n = 6, respectively) injected with the same volume of PBS instead of Con A were served as controls. All the mice were bled and sacrificed at 24 h after Con A administration ([Fig. 5](#fig5){ref-type="fig"}A). Serum samples and resected livers of all the mice were subjected to the analyses.Fig. 5Therapeutic effect of heparin on Con A-induced liver injury.(A) Experimental scheme. (B) Serum ALT levels 24 h after Con A administration with or without heparin in ND and HFD4 mice. The data are shown as means ± SD (U/l). \*p \< 0.05.(C) H&E staining of representative liver sections from the individual groups of mice 24 h after Con A administration. From left to right, ND mice, ND mice with heparin, HFD4 mice, and HFD4 mice with heparin, respectively. Arrow heads indicate degenerated hepatocytes (HFD4 mice with heparin). 4× objective\'s scale bar: 200 μm 10× objective\'s scale bar: 50 μm 20× objective\'s scale bar: 20 μm. (D) Fibrin/fibrinogen immunostaining of serial liver sections from the same mice as (C). 10× objective\'s scale bar: 50 μm 20× objective\'s scale bar: 20 μm.Fig. 5

2.5. Biochemical and coagulation-related tests {#sec2.5}
----------------------------------------------

Sera were subjected to biochemical tests: alanine aminotransferase (ALT), total cholesterol (T-Cho), triglyceride (TG), and glucose (Glu) levels, and plasma to coagulation-related tests: fibrinogen and D-dimer levels. Measurement of these items was entrusted to SRL Inc. (Tokyo, Japan).

2.6. Histological analysis {#sec2.6}
--------------------------

Liver tissues of sacrificed mice were fixed in 10 N formaldehyde (Mildform, Fujifilm Wako), embedded in paraffin, and sectioned at 3 μm thickness. The tissue sections were stained with haematoxylin & eosin (H&E), or used for immunostaining of fibrinogen/fibrin or 8-hydroxy-2′-deoxyguanosine (8-OHdG), according to the protocol provided by the manufacturer (Cell Signal Technology (CST), Inc., MA, USA). For the immunostaining, rabbit anti-fibrinogen antibody (\#189490, Abcam plc, Cambridge, UK) or Anti-8-OHdG polyclonal antibody (bs-1278R, Bioss Antibodies Inc., MA, U.S.A.) was used as a primary antibody, and SignalStain® Boost IHC Detection Reagent (HRP, Rabbit, \#8114, CST, Inc.) as a secondary antibody. It should be noted that the primary antibody for fibrinogen/fibrin immunostaining (\#189490) does not distinguish between fibrinogen and fibrin. In order to stain liver fat, unfixed liver tissue was embedded with O.C.T. Compound (Sakura Finetek Japan, Tokyo, Japan) and frozen in liquid nitrogen to prepare a frozen specimen. Oil Red O staining was used for fat staining.

2.7. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) {#sec2.7}
---------------------------------------------------------------------------

Quantitative real-time reverse-transcription polymerase chain reaction (qRT-PCR) was performed using total RNA prepared from resected mouse livers with NucleoSpin RNA (Macherey-Nagel GmbH & Co. KG, Düren, Germany). The RNA was subjected to first-strand cDNA synthesis using PrimeScript RT Master Mix (Takara Bio Inc., Shiga, Japan) according to the manufacturer\'s instructions. qRT-PCR was performed with Thermal Cycler Dice® Real Time System II (Takara Bio Inc.) using TB Green Premix Ex Taq II (Tli RnaseH Plus, Takara Bio Inc., Shiga, Japan) and ROX Reference Dye (Takara Bio Inc.). The PCR amplification was conducted as follows; an initial denaturing step, at 95 °C for 30 s; followed by 40 cycles, at 95 °C for 5 s; at 60 °C for 31 s. Each sample was analyzed in duplicate. Measured genes (glycolysis-related enzymes, cytokines/chemokines, cell surface markers, coagulation-related molecules, ER stress-related molecules, hypoxia and oxidative stress-related molecules) and their primers are listed in [Table 2](#tbl2){ref-type="table"}.Table 2Primer sequences for real-time PCR.Table 2GeneForward primer sequences (5\'\--3′)Reverse primer sequences (5\'\--3′)*Gapdh*TGTGTCCGTCGTGGATCTGATTGCTGTTGAAGTCGCAGGAG*Hk4*CATCCTGCTCAACTGGACCAACATTGCCACCACATCCATCTC*Gpi1*GTGGTCAGCCATTGGACTTTCTTTCCGTTGGACTCCATGT*Pdk4*AGTGACTCAAAGACGGGAAACGTGTGAGGTTTAATTCTGGCG*Ifng*CGGCACAGTCATTGAAAGCCTAGTTGCTGATGGCCTGATTGTC*Il1a*TGGTTAAATGACCTGCAACAGGAAAGGTCGGTCTCACTACCTGTGATG*Il6*CCACTTCACAAGTCGGAGGCTTACCAGTTTGGTAGCATCCATCATTTC*Il10*GCCAGAGCCACATGCTCCTAGATAAGGCTTGGCAACCCAAGTAA*Tnfα*TATGGCCCAGACCCTCACAGGAGTAGACAAGGTACAACCCATC*Mcp1*AGCAGCAGGTGTCCCAAAGAGTGCTGAAGACCTTAGGGCAGA*Cd11b*CCACTCATTGTGGGCAGCTCGGGCAGCTTCATTCATCATGTC*Cd11c*AGGTCTGCTGCTGCTGGCTAGGTCCCGTCTGAGACAAACTG*F4/80*TTGCAAAGTCCTGTGTGCTCTGCCATCAACTCATGATACCCT*Ly6c*TGCCTGCAACCTTGTCTGAGGCTGGGCAGGAAGTCTCAAT*Ly6g*TTGCAAAGTCCTGTGTGCTCGTCCAGAGTGGGGCAGA*Tf*TGTGCACCGAGCAATGGAAGCTTGCACAGAGATATGCA*Pai1*TGCTGAACTCATCAGACAATGGAAGTCGGCCAGGGTTGCACTAA*Fbgα*TGTGGAGAGACATCAGAGTCAATGCGTCAATCAACCCTTTCATCC*Bip*GAACCAACTCACGTCCAAGCAATAGTGCCAGCATCT*Xbp1*CTGAGTCCGAATCAGGTGCAGGTCCATGGGAAGATGTTCTGG*Atf4*GCCTGACTCTGCTGCTTAGCCTTACGGACCTCTTC*Atf6*TTCCCAGGATTTCAGCAGGTTTCAGCATCAGGAATGCGTGT*Chop*TCCCTGCCTTTCACCTTGCGTTCTCCTGCTCCTTCTC*Hif1a*TCAAGTCAGCAACGTGGAAGTATCGAGGCTGTGTCGACTG*Ho1*CCTCACTGGCAGGAAATCATCCCTCGTGGAGACGCTTTACATA*Mnsod*GCACATTAACGCGCAGATCAAGCCTCCAGCAACTCTCCTT

2.8. Statistical analysis {#sec2.8}
-------------------------

All the values were expressed as the mean ± SD (standard deviations). Data were analyzed by Mann-Whitney U tests for two group comparison or two-way analysis of variance test (ANOVA) followed by Steel-Dwass tests for multiple group comparison. All statistical analyses were performed with EZR (Saitama Medical Center, Jichi Medical University, Saitama, Japan), which is a graphical user interface for R (The R Foundation for Statistical Computing, Vienna, Austria). P values less than 0.05 were considered statistically significant.

3. Results {#sec3}
==========

3.1. Alteration of biochemical and coagulation-related tests, and liver histology by HFD feeding {#sec3.1}
------------------------------------------------------------------------------------------------

We analyzed the influence of short-term HFD intake on biochemical and coagulation-related tests, and liver histology. In the serum biochemical tests, ALT levels were not different between ND, HFD4, and HFD14 mice, while the levels of T-Cho, TG, and Glu mostly increased in HFD-fed mice compared with those in ND mice (n = 5, respectively). No significant difference was found in any of the items between HFD4 and HFD14 mice ([Fig. 1](#fig1){ref-type="fig"}B, Suppl [Table 1](#appsec1){ref-type="sec"}). In correspondence to these results, body wait significantly increased in HFD4 and HFD14 compared with that in ND (p \< 0.05 Suppl [Table 1](#appsec1){ref-type="sec"}).

In the plasma coagulation-related tests, D-dimer levels remained under detection level in all the samples (ND, HFD1, HFD2, and HFD4) suggesting that fibrin degeneration as well as fibrin clot formation did not occur during HFD intake for 4 days. Fibrinogen levels tended to be low in HFD1 and HFD2 mice compared with those in ND mice, and fibrinogen levels in HFD4 mice showed tendency to recover to the levels in ND mice ([Table 2](#tbl2){ref-type="table"}).

In the H&E stained liver histology, fat depositions in hepatocytes and inflammatory changes in the liver, such as degeneration of hepatocytes and inflammatory cell infiltration, did not seem obvious in all the group of mice ([Fig. 1](#fig1){ref-type="fig"}C). However, Oil Red O staining showed deposition of small fat droplets in most of the hepatocytes in HFD4 and HFD14 mice. The extent of fat deposition did not seem different between the two groups of mice ([Fig. 1](#fig1){ref-type="fig"}D). The immunostaining for fibrinogen/fibrin showed extensive deposition of fibrinogen/fibrin in the liver sinusoids, especially in line with their walls, in HFD4 and HFD14 mice, while it was not evident in ND mice ([Fig. 1](#fig1){ref-type="fig"}C). It was thought that appearance of the fibrinogen/fibrin deposition in the sinusoids related to the temporal decrease in the plasma fibrinogen levels in HFD-fed mice, meaning the possibility that the deposition observed in the sinusoids were derived from plasma fibrinogen.

3.2. Alteration of hepatic mRNA expression patterns related to metabolism {#sec3.2}
-------------------------------------------------------------------------

In the mRNA expression analysis of glycolysis-related enzymes, hexokinase-4 (HK-4) and glucose-6-phosphatase isomerase (GPI-1) mRNA levels showed significant increase in HFD-fed mice compared with those in ND mice (HK-4: ND vs. HFD4, p \< 0.05; GPI-1: ND vs. HFD4 and HFD14, p \< 0.05, respectively), suggesting the acceleration of glycolysis pathway in HFD-fed mice. Significant decrease of pyruvate dehydrogenase kinase 4 (PDK4) mRNA levels were observed in HFD-fed mice compared with those in ND mice (p \< 0.05), and it also suggests the acceleration of glycolysis pathway in HFD-fed mice. On the other hand, the decrease of PDK4 mRNA expression suggests suppression of fatty acid β-oxidation, and increase of free fatty acid and triglyceride synthesis, which may be associated with the biochemical and histological findings in HFD-fed mice \[[@bib18],[@bib19]\] ([Fig. 2](#fig2){ref-type="fig"}).

Although increase of serum Glu, T-Cho, and TG levels suggests the presence of insulin resistance, efficiency of Glu metabolism were not seriously disturbed considering mRNA expression patterns of the glycolysis-related enzymes. Since the development of insulin resistance is a key factor that leads to NAFLD and NASH, performing insulin resistant test need to be considered in further study.

3.3. Alteration of hepatic mRNA expression patterns related to cytokine/chemokine, cell surface marker, and coagulation {#sec3.3}
-----------------------------------------------------------------------------------------------------------------------

We analyzed the hepatic mRNA expression of inflammatory cytokines/chemokines, cell surface markers of bone marrow-derived inflammatory cells, and coagulation-related factors in ND- and HFD-fed mice. The mRNA expression of inflammatory cytokines/chemokines such as IFN-γ, TNF-α, MCP-1, and IL-10 showed significant increase in HFD-fed mice (HFD4 and/or HFD14) compared with ND mice (p \< 0.05). However, mRNA levels of IL-1 and IL-6 were not different between the three groups of mice.

In the analysis of mRNA levels of cell surface markers, CD11b and F4/80 mRNA levels were significantly elevated in HFD14 mice compared with those in ND mice (p \< 0.05). And Ly6G mRNA levels markedly increased in HFD14 mice compared with those in ND and HFD4 mice (p \< 0.05). The results suggest the increase of monocyte, NK cell, and neutrophil migration and KC expansion in the livers of HFD14 mice. Since these does not necessarily correspond to the histology, we should consider immunostaining of liver tissues or flow cytometric analysis for liver-infiltrating or resident inflammatory cells to confirm the results in further study. Anyway, mRNA expression patterns of both cytokines/chemokines and cell surface markers indicate the induction of inflammatory responses in the liver even by the short-term HFD diet ([Fig. 2](#fig2){ref-type="fig"}).

We examined mRNA levels of TF, PAI-1, and fibrinogen-α (Fbg-α) as coagulation-related factors, which are known to be augmented by inflammatory response \[[@bib20]\]. TF and PAI-1 mRNA levels significantly increased in HFD14 mice (p \< 0.05), and TF mRNA levels tended to increase in HFD4 mice, compared with those of ND mice (p = 0.064). In contrast, Fbg-α mRNA levels significantly decreased in HFD4 and HFD14 mice compared with that in ND mice. The decrease of fibrinogen mRNA levels in HFD-fed mice is possibly explained by downregulation due to the elevated extracellular sterols (cholesterol and 25-hydroxycholesterol) \[[@bib21]\] ([Fig. 2](#fig2){ref-type="fig"}).

3.4. Alteration of hepatic mRNA expression patterns related to cellular stresses {#sec3.4}
--------------------------------------------------------------------------------

ER stress pathway is known to be influenced by the alteration of metabolism, and its activation triggers inflammatory reactions, and is thought to associate with the development of NASH \[[@bib22]\]. Therefore, in order to examine the involvement of ER stress pathway on the inflammatory reactions observed in the livers of HFD-fed mice, we analyzed mRNA expression of ER stress-related genes: binding immunoglobulin protein (BiP), X-box-binding protein (XBP-1), activating transcription factor 4 (ATF4), activating transcription factor 6 (ATF6), and C/EBP homologous protein (CHOP) in the livers of ND- and HD-fed mice. There were no differences in mRNA expression levels of ATF4 and ATF6 between ND, HFD4, and HFD14. However, mRNA levels of BiP in HFD4, and CHOP in HFD4 and HFD14 significantly increased, and that of XBP-1 in HFD14 significantly decreased, compared with those in ND mice (p \< 0.05, respectively), indicating the induction of ER stress responses with short-term HFD intake. The decrease of XBP-1 mRNA levels during HFD intake implies the downregulation of ER associated degradation (ERAD) mechanism that reduces ER stress, conversely meaning the increase of ER stress. And the increase of CHOP mRNA levels suggests the increase of not only ER stress but also susceptibility to apoptosis of hepatocytes ([Fig. 2](#fig2){ref-type="fig"}).

We also examined mRNA expression of the genes related to hypoxia and oxidative stress responses. To evaluate hypoxia response which is possibly induced by acceleration of mitochondrial aerobic metabolism \[[@bib23]\], we examined mRNA levels of hypoxia-inducible factor-1α (HIF-1α). But we could not find difference in the HIF-1α mRNA levels between ND- and HFD-fed mice. mRNA levels of heme oxygenase-1 (HO-1) and Mn-superoxide dismutase (MnSOD) were examined to assess oxidative stress response in the liver. HO-1 mRNA levels were not different between ND- and HFD-fed mice, but MnSOD mRNA levels were significantly lower in HFD14 mice than in ND mice (p \< 0.05). It has been reported that expression of MnSOD mRNA is negatively correlated with increased hepatic fat storage in the male mice \[[@bib24]\], and our results seems consistent with this report ([Fig. 2](#fig2){ref-type="fig"}).

We observed the induction of ER stress response and decrease of MnSOD expression in the liver of mice fed with short-term HFD. However, 8-OHdG immunostaining of these liver tissues did not show positive staining areas except for the necro-inflammatory lesions caused by Con A administration, even in HFD-fed mice (Suppl [Fig. 1](#appsec1){ref-type="sec"}).

3.5. Influence of HFD feeding on the severity of Con A-induced liver injury {#sec3.5}
---------------------------------------------------------------------------

Next, we compared severity of Con A-induced liver injury between ND- and HFD-fed mice. In ND mice, serum ALT levels 24 h after Con A administration was 302 ± 227 U/l. In HFD4 and HFD14 mice, ALT levels were 4675 ± 2211 U/l and 3950 ± 2210 U/l, respectively, both showing significant elevation compared with those of ND mice (p \< 0.05, respectively, [Fig. 3](#fig3){ref-type="fig"}B, Suppl [Table 1](#appsec1){ref-type="sec"}).

In histological analysis, relatively small, scattered necro-inflammatory lesions were found in ND mice, while larger necro-inflammatory lesions were extensively observed in HFD4 and HFD14 mice ([Fig. 3](#fig3){ref-type="fig"}C). The extent of liver damage in the histology did not differ between HFD4 and HFD14 mice consistent with the ALT levels.

The immunostaining for fibrinogen/fibrin showed the deposition of fibrinogen/fibrin in the areas almost consistent with widespread necro-inflammatory lesions, both in HFD4 and HFD14 mice. In ND mice, small necro-inflammatory lesions and liver sinusoids in the lobules were positive for the staining ([Fig. 3](#fig3){ref-type="fig"}D).

3.6. Kinetics of hepatic mRNA expression patterns in the early phase of Con A-induced liver injury {#sec3.6}
--------------------------------------------------------------------------------------------------

Serial changes in ALT levels, liver histology, and hepatic mRNA expression patterns in ND and HFD4 mice were investigated 1 and 3 h after Con A administration ([Fig. 4](#fig4){ref-type="fig"}A), since the hepatic inflammatory reactions in this time period have been known to determine the magnitude of liver injury in this model \[[@bib15]\]. Serum ALT levels and liver histology showed no significant changes in both groups during the observation period up to 3 h, although marked elevation of ALT levels and wide-spread necro-inflammatory lesions were observed at 24 h after Con A administration only in HFD4 mice ([Fig. 4](#fig4){ref-type="fig"}B and C), consistent with the results in the former experiment. In the analysis for hepatic mRNA expression levels of cytokines/chemokines, those of IFN-γ, IL-1α, IL-6, IL-10 peaked at 1 h after Con A administration, while those of TNF-α and MCP-1 increased over time until 3 h after Con A administration ([Fig. 4](#fig4){ref-type="fig"}D). mRNA expression patterns of cell surface markers suggested increased migration of monocytes/macrophages, NK cells, and neutrophils in both groups of mice, but decrease of KCs in HFD4 mice. There were no apparent differences in mRNA expression patterns of cytokines/chemokines and cell surface markers between ND and HFD4 mice, except for those of F4/80 which showed decrease in HFD4 mice and no apparent change in ND mice ([Fig. 4](#fig4){ref-type="fig"}D).

mRNA levels of coagulation-related molecules increased over time until 3 h after Con A administration in both groups of mice. They also showed no marked differences between the two groups, except for TF mRNA levels. Namely, TF mRNA levels at 3 h after Con A administration were significantly higher in HFD4 than in ND (p \< 0.05, [Fig. 4](#fig4){ref-type="fig"}D).

There were also no big differences in mRNA expression patterns of ER stress-, hypoxia-, and oxidative stress-related genes between ND and HFD4 mice. The elevation of BiP, XBP-1, CHOP, HO-1, and MnSOD mRNA levels suggested the existence of ER and oxidative stresses induced by Con A administration.

3.7. Heparin treatment against the Con A-induced liver injury {#sec3.7}
-------------------------------------------------------------

Then, we pretreated mice with heparin prior to Con A administration to examine how hypercoagulability is related to the severity of liver injury. In ND mice, ALT levels 24 h after Con A administration were significantly decreased in heparin-treated mice (36 ± 9 U/l) compared with non-treated mice (434 ± 175 U/l, p \< 0.05). In HFD4 mice, ALT levels 24 h after Con A administration showed more significant decline by heparin treatment: non-treated mice, 5934 ± 2706 U/l; heparin-treated mice, 112 ± 78 U/l (p \< 0.05). ALT levels 24 h after Con A administration in the mice with heparin treatment still tended to be higher in HFD4 mice than in ND mice (p = 0.059, [Fig. 5](#fig5){ref-type="fig"}A and B, Suppl [Table 1](#appsec1){ref-type="sec"}). In ND mice, the liver histology in heparin-treated mice showed significant improvement in inflammation, without apparent necro-inflammatory lesions and degenerated hepatocytes. In HFD4 mice, the extent of improvement in liver histology by the heparin treatment was more prominent than that in ND mice. In heparin-treated HFD4 mice, widespread necro-inflammatory lesions were almost disappeared, while scattered degenerated hepatocytes were observed consistent with the slightly elevated ALT levels ([Fig. 5](#fig5){ref-type="fig"}C).

In the analysis of hepatic mRNA expression patterns of the mice before Con A administration, heparin treatment did not affect mRNA expression levels of most of the cytokine/chemokine, coagulation- and ER stress-related genes both in ND and HFD4 mice. There were only two exceptions: TNF-α mRNA levels in HFD4 mice showed slight but significant elevation, and XBP-1 mRNA in ND mice showed significant decline by the heparin treatment (p \< 0.05, respectively). Most of other changes in mRNA levels were associated with liver injury by Con A administration or amelioration of Con A-induced liver injury by the heparin treatment (Supple [Fig. 2](#appsec1){ref-type="sec"}).

Fibrinogen/fibrin immunostaining for the liver tissues of heparin-treated mice 24 h after Con A administration, showed strong deposition of fibrinogen/fibrin in the sinusoids both in ND and HFD4 mice. Considering the increase of Fbg-α mRNA levels by Con A administration and efficient inhibition of clot formation of fibrin by heparin treatment, it is strongly suggested that the deposition detected in the sinusoids was fibrinogen, not fibrin clot ([Fig. 5](#fig5){ref-type="fig"}D).

4. Discussion {#sec4}
=============

In the current study, we indicated that just short-term HFD intake for just 4 days, induced proinflammatory and procoagulation states in the livers of mice.

As described, Cleuren et al. have reported that HFD intake for 14 days induces increase of plasma levels of inflammatory cytokines and coagulation factors in mice, while the mechanism for this is not clearly elucidated \[[@bib5]\]. It has also been reported that HFD intake for 3 days can induces activation of inflammatory/immune pathways in mice livers which are mainly controlled by nuclear factor-κB (NFκB) signaling \[[@bib25]\]. Since the close relationship between inflammatory cytokines and coagulation-related factors, such as TF, has been reported \[[@bib20],[@bib26],[@bib27]\], we thought that HFD-induced NFκB activation lead to the development of proinflammatory state and subsequently to the development of procoagulation state.

In the analysis of gene expressions related to glucose metabolism, we observed the suppression of PDK4 mRNA level by HFD intake ([Fig. 2](#fig2){ref-type="fig"}), which suggests the increase of acetyl-CoA production and the acceleration of aerobic metabolic pathway, usually leading to the increased production of reactive oxygen species (ROS) in mitochondria \[[@bib28]\]. It has also been reported that hyperglycemia or hyperlipidemia themselves induce mitochondrial ROS production \[[@bib29],[@bib30]\]. Since ROS is known to activate ER stress pathways, or directly induce inflammatory cytokines, such as TNF-α \[[@bib28],[@bib31]\], it may also explain the mechanism that induced proinflammatory state in HFD-fed mice in the current study.

It is recently reported that the transition of diet consumption between fasting and feeding immediately induces ER stress responses in the liver of mice \[[@bib32]\]. While we cannot clarify the relevance of the report to our findings, we similarly observed the increased mRNA levels of BiP and CHOP in the livers of the mice with just short-term HFD intake ([Fig. 2](#fig2){ref-type="fig"}). We expected the activation of inositol requiring 1 (IRE1) pathway, one of the major ER stress pathways which is known to activate NFκB signaling, but we could not indicate the direct evidence for that in the current study. We also expected the involvement of hypoxia- and oxidative stress-related factors in the induction of inflammatory responses during short-term HFD, but we could not show the significant changes in mRNA expression of these factors ([Fig. 2](#fig2){ref-type="fig"}). In 8-OHdG immunostaining, no apparent oxidative DNA damage were detected in HFD-fed mice with or without Con A administration, except in the necrotic lesions in Con A administered-mice (Suppl [Fig. 1](#fig1){ref-type="fig"}). These suggest that the cellular stresses induced by short-term HFD were enough to provoke inflammatory responses in the liver, but not enough to cause apparent oxidative DNA damage to the liver cells. Since the involvement of cellular stresses is the feature of NASH pathogenesis and the current study showed the induction of hepatic cellular stresses by short-term HFD intake, it is required to investigate the relationship between duration of HFD diet and induction of cellular stresses.

We observed the increase of IFN-γ and IL-10 mRNA expression as well as that of TNF-α and MCP-1 in the liver of HFD-fed mice ([Fig. 2](#fig2){ref-type="fig"}). We assumed the involvement of NFκB signaling pathways in hepatocytes for the induction of proinflammatory states in the short-term HFD loading, but at least IFN-γ is not produced by hepatocytes. The current study suggested the increase of monocytes, NK cells, and neutrophils, and the expansion of KCs in the livers of HFD-fed mice. There are many inflammatory stimuli circulating to the liver, such as lipopolysaccharide and secondary bile acids, which are the candidates of so-called "second hits" as suggested in NASH pathogenesis. Therefore, it is thought that these "second hits" stimulate liver-resident KCs, LSECs, HSCs, and DCs to produce cytokines and chemokines, causing activation of immune cells, some of which produced IFN-γ. Moreover, it has also been reported that the functions of KCs, LSECs, and HSCs are modulated directly by HFD loading \[[@bib17],[@bib33],[@bib34]\], and they possibly cause the activation of IFN-γ producing immune cells. The exact mechanism for the induction of proinflammatory state by HFD need to be elucidated in detail in further study.

Importantly, we indicated that severity of Con A-induced liver injury was greatly exacerbated with short-term (for 4 days) HFD intake even in the absence of obvious fatty liver in the mouse model ([Fig. 1](#fig1){ref-type="fig"}C).

In the Con A-induced liver injury model, it has been reported that IFN-γ and TNF-α mainly produced from Con A-stimulated T cells facilitate the production of TF and PAI-1, resulting in the induction of procoagulation state, and that subsequent thrombus formation in sinusoids causes extensive liver necrosis \[[@bib15]\]. Con A-induced liver injury is considered as a model of autoimmune hepatitis, but thrombus formation subsequent to the liver damage, is recognized as a common pathology of severe liver injury \[[@bib35]\]. Indeed, it has been proven that the deposition of fibrin as intravascular microthrombi obstruct local hepatic blood flow causing extended liver damage in many of the liver injury model \[[@bib36],[@bib37]\].

We observed increased deposition of fibrinogen in the liver sinusoids in HFD-fed mice without the increase of plasma levels and hepatic mRNA expression levels of fibrinogen ([Figs. 1](#fig1){ref-type="fig"}C and [2](#fig2){ref-type="fig"}, [Table 3](#tbl3){ref-type="table"}). It has been reported in the human study that even single HFD causes the decrease of flowmediated vasodilation inversely proportional to the serum TG levels, and that saturated fatty acids induce an increased expression of the proinflammatory adhesion molecules, such as intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) on epithelial cells \[[@bib38]\]. It has also been reported that 6--10 weeks of choline deficient, amino-acid defined HFD enhances expression of integrin α5β1 \[[@bib39]\], a ligand of fibrinogen \[[@bib40]\]. Therefore, it is speculated that HFD causes the disturbance of blood flow in liver sinusoids and the enhancement of integrin expression including α5β1, resulting in the increased deposition of fibrinogen in sinusoids. The results of immunostaining of fibrinogen/fibrin in the Con A-administered mice suggests that the deposition of fibrinogen/fibrin were increased by inflammation, probably through the enhanced expression of fibrinogen and integrins on LSECs ([Fig. 5](#fig5){ref-type="fig"}D). From the results in the current study, we believe that the deposition of fibrinogen together with the increase of TF and PAI-1 expression induced by short-term HFD played the significant role in the exacerbation of liver injury. However, the mechanism of fibrinogen deposition in sinusoids, especially the involvement of LSECs, should be further examined in detail to clarify the potential risk of HFD intake.Table 3Plasma fibrinogen and D-dimer.Table 3Fibrinogen (mg/dl)D-dimer (μg/ml)ND\<50\<0.179\<0.1148\<0.1143\<0.1HFD1\<50n.d.\<50n.d.\<50n.d.\<50n.d.HFD2\<50n.d.\<50n.d.116n.d.98n.d.HFD480\<0.1163\<0.1135\<0.1120\<0.1[^1]

Since the dose of Con A administered to mice in the current experiment was the half of the usual experiment, the extent of liver injury was relatively low compared to the reports dealing with Con A liver injury model. But it was amplified about ten times in ALT levels by the short-term HFD intake. We think this partly implies the possible mechanism for the development of NASH as suggested in "multiple parallel hits theory" \[[@bib8]\]. Namely, diet-related oxidative stress, production of ROS, and ER stress may cause proinflammatory and procoagulation states in the liver, and increase the susceptibility of hepatocytes against many inflammatory stimuli circulating to the liver, like lipopolysaccharide and secondary bile acids, produced or metabolized by gut microbes. Along with the progression of hepatic triglyceride accumulation or steatosis, these may cooperatively cause progressive inflammatory and fibrotic change in the liver, finally leading to the development of NASH.

To prove the hypothesis above, we should consider examining the susceptibility to liver injury in the HFD-fed mice using more physiological stimuli, such as lipopolysaccharide. The influence of HFD intake in a wider range of duration should also be evaluated, referring the report about the transition of hepatic mRNA expression patterns during HFD feeding \[[@bib25]\]. Furthermore, the influence of HFD intake in other background of mice should be examined to evaluate the relevance of genetic factors to the development of NASH is reported in human study \[[@bib41],[@bib42]\].

In the current study, we reported that just short-term HFD intake increased the susceptibility of the liver to inflammatory stimuli through the induction of procoagulation state in the livers of mice. We think that it explains a part of NASH pathogenesis, and appears to support the previously reported effects of anticoagulant therapy on NAFLD and NASH \[[@bib43],[@bib44]\].
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[^1]: Experiment using positive control (LPS) was done as follows:100 μg/body of LPS (Lipopolysaccharide from *E. coli* 0111: B4, Chondrex, Inc., WA, U.S.A.) was administered to 8 weeks old male C57BL/6 mouse fed with ND, and blood sample was collected 24 h after LPS administration. Plasma fibrinogen, and D-dimer levels were 261 mg/dl, 0.32 μg/ml, respectively. n.d: not done.
